Sernova Biotherapeutics Inc.

News & Events

Press Releases

In The Media

1. Sernova Biotherapeutics Provides Positive Interim Data from Ongoing Phase 1/2 Clinical Trial of Cell Pouch Bio-hybrid Organ in Patients Living with Type 1 Diabetes

   GlobeNewswire MAY 14, 2025 7:00 AM EDT
   Clinical Study on Track to Meet its Primary and Secondary Endpoints Data Demonstrate That...
   READ ARTICLE

2. Sernova Biotherapeutics Secures $4 Million Loan to Further Advance its Clinical Development Plans

   GlobeNewswire APR 17, 2025 8:00 AM EDT
   LONDON, Ontario and BOSTON, April 17, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA...
   READ ARTICLE

3. Sernova Biotherapeutics Cell Pouch Bio-hybrid Organ to be Highlighted at Cell & Gene Meeting on the Med

   GlobeNewswire APR 15, 2025 4:05 PM EDT
   LONDON, Ontario and BOSTON, April 15, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA...
   READ ARTICLE

4. Sernova Biotherapeutics Provides Update on Phase 1/2 Clinical Trial of Cell Pouch(TM) Bio-Hybrid Organ for Treatment of Type 1 Diabetes

   GlobeNewswire APR 1, 2025 8:00 AM EDT
   DSMB supports advancement for Sernova’s clinical trial Study is on track to meet k...
   READ ARTICLE

5. Sernova Biotherapeutics Appoints Pericles Calias, Ph.D. as Chief Development Officer and Head of R&D

   GlobeNewswire MAR 10, 2025 8:00 AM EDT
   LONDON, Ontario and BOSTON, March 10, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA...
   READ ARTICLE

6. Sernova Biotherapeutics Secures $1 Million Convertible Debt Financing

   GlobeNewswire MAR 5, 2025 8:00 AM EST
   LONDON, Ontario and BOSTON, March 05, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA...
   READ ARTICLE

7. Sernova Biotherapeutics Receives FDA Clearance for IND Application for its Cell Pouch Bio-hybrid Organ with Autograft Thyroid Cells in Patients with Hypothyroidism

   GlobeNewswire MAR 3, 2025 9:00 AM EST
   LONDON, Ontario and BOSTON, March 03, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA...
   READ ARTICLE

8. Sernova Biotherapeutics Submits IND Application for its Cell Pouch Bio-Hybrid Organ with Autograft Thyroid Cells in Patients with Hypothyroidism

   GlobeNewswire FEB 3, 2025 8:00 AM EST
   LONDON, Ontario and BOSTON, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA)...
   READ ARTICLE

9. Sernova Announces Appointment of Ross Haghighat as Chair of the Board and a Change of Name to Sernova Biotherapeutics

   GlobeNewswire JAN 30, 2025 8:00 AM EST
   LONDON, Ontario and BOSTON, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA)...
   READ ARTICLE

10. Sernova Announces Voting Results from its Annual and Special General Meeting of Shareholders

    GlobeNewswire JAN 13, 2025 8:00 AM EST
    LONDON, Ontario and BOSTON, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX: SVA) (OTCQB: SE...
    READ ARTICLE